Insider Trading Alert - CCOI, CRM And SGMO Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 13, 2014, 88 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $292.00 to $15,496,000.00.

Highlighted Stocks Traded by Insiders:

Cogent Communications Holdings (CCOI) - FREE Research Report

Kummer Raymond B, who is CTO; VP Optical Transport at Cogent Communications Holdings, sold 6,000 shares at $35.51 on Nov. 13, 2014. Following this transaction, the CTO; VP Optical Transport owned 68,940 shares meaning that the stake was reduced by 8.01% with the 6,000-share transaction.

The shares most recently traded at $35.33, down $0.18, or 0.5% since the insider transaction. Historical insider transactions for Cogent Communications Holdings go as follows:

  • 4-Week # shares sold: 1,000
  • 12-Week # shares sold: 15,750
  • 24-Week # shares sold: 42,500

The average volume for Cogent Communications Holdings has been 352,900 shares per day over the past 30 days. Cogent Communications Holdings has a market cap of $1.6 billion and is part of the technology sector and telecommunications industry. Shares are down 12% year-to-date as of the close of trading on Thursday.

Cogent Communications Holdings, Inc., through its subsidiaries, provides high-speed Internet access and Internet protocol communications service. The stock currently has a dividend yield of 3.55%. The company has a P/E ratio of 30.6. Currently, there are 5 analysts who rate Cogent Communications Holdings a buy, 2 analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CCOI - FREE

TheStreet Quant Ratings rates Cogent Communications Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Cogent Communications Holdings Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Salesforce.com (CRM) - FREE Research Report

Norton Burke F, who is EVP and Chief Legal Officer at Salesforce.com, sold 5,000 shares at $63.52 on Nov. 13, 2014. Following this transaction, the EVP and Chief Legal Officer owned 49,851 shares meaning that the stake was reduced by 9.12% with the 5,000-share transaction.

The shares most recently traded at $63.40, down $0.12, or 0.19% since the insider transaction. Historical insider transactions for Salesforce.com go as follows:

  • 4-Week # shares sold: 295,000
  • 12-Week # shares sold: 987,820
  • 24-Week # shares sold: 2.0 million

The average volume for Salesforce.com has been 4.9 million shares per day over the past 30 days. Salesforce.com has a market cap of $39.5 billion and is part of the technology sector and computer software & services industry. Shares are up 14.44% year-to-date as of the close of trading on Thursday.

salesforce.com, inc. provides enterprise cloud computing solutions to various businesses and industries worldwide. Currently, there are 23 analysts who rate Salesforce.com a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CRM - FREE

TheStreet Quant Ratings rates Salesforce.com as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and generally higher debt management risk. Get the full Salesforce.com Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Sangamo BioSciences (SGMO) - FREE Research Report

Wolff Henry Ward, who is Exec VP & CFO at Sangamo BioSciences, sold 2,000 shares at $11.37 on Nov. 13, 2014. Following this transaction, the Exec VP & CFO owned 213,353 shares meaning that the stake was reduced by 0.93% with the 2,000-share transaction.

The shares most recently traded at $11.43, up $0.06, or 0.49% since the insider transaction. Historical insider transactions for Sangamo BioSciences go as follows:

  • 4-Week # shares sold: 2,500
  • 12-Week # shares sold: 7,500
  • 24-Week # shares sold: 15,298

The average volume for Sangamo BioSciences has been 836,700 shares per day over the past 30 days. Sangamo BioSciences has a market cap of $827.0 million and is part of the health care sector and drugs industry. Shares are down 15.55% year-to-date as of the close of trading on Thursday.

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Currently, there are 4 analysts who rate Sangamo BioSciences a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SGMO - FREE

TheStreet Quant Ratings rates Sangamo BioSciences as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income and weak operating cash flow. Get the full Sangamo BioSciences Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

What Market Selloff? Dow Futures Are Popping on Sunday

What Market Selloff? Dow Futures Are Popping on Sunday

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric